Most recently, exome-wide sequencing has identified the rs72613567:TA variant within hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13), which was associated with a decreased risk of alcoholic liver disease, NASH, alcoholic cirrhosis, and NASH cirrhosis[53]. Here, HSD17B13 is linked to metabolic dysfunction-associated steatohepatitis.